M2 PRESSWIRE-24 April 2007-US FDA: FDA Approves First Generic Versions of Ambien (Zolpidem Tartrate) for the Treatment of Insomnia(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:23042007 The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.
Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
Market-based government through innovation: How public sector leaders are improving collaboration and focusing on citizens
Zolpidem (ZOLE-pi-dem) tartrate is a sedative-hypnotic drug indicated for the short-term treatment of insomnia. “The FDA’s Office of Generic Drugs ensures that generic drugs are safe and effective for the American public through a rigorous scientific and …
Read the rest of this article with a Free Trial at HighBeam Research.